2006
P5-40 T-wave amplitude is a more sensitive marker of myocardial ischemia than ST-segment changes in patients undergoing exercise stress testing
Naidu S, Shusterman V, Howes C, Cleman M, O’Connor M, Goldberg A, Lampert R. P5-40 T-wave amplitude is a more sensitive marker of myocardial ischemia than ST-segment changes in patients undergoing exercise stress testing. Heart Rhythm 2006, 3: s273. DOI: 10.1016/j.hrthm.2006.02.818.Peer-Reviewed Original Research
1991
Validation of continuous radionuclide left ventricular functioning monitoring in detecting silent myocardial ischemia during balloon angioplasty of the left anterior descending coronary artery
Kayden D, Remetz M, Cabin H, Deckelbaum L, Cleman M, Wackers F, Zaret B. Validation of continuous radionuclide left ventricular functioning monitoring in detecting silent myocardial ischemia during balloon angioplasty of the left anterior descending coronary artery. The American Journal Of Cardiology 1991, 67: 1339-1343. PMID: 2042565, DOI: 10.1016/0002-9149(91)90462-t.Peer-Reviewed Original ResearchConceptsSilent myocardial ischemiaLV ejection fractionLV dysfunctionMyocardial ischemiaEjection fractionLV functionBalloon inflationRelative end-systolic volumeTransient ST-segment depressionPercutaneous transluminal coronary angioplastyMean LV ejection fractionST-segment depressionContinuous electrocardiographic monitoringTransluminal coronary angioplastyLeft ventricular functionST-segment changesEnd-diastolic volumeEnd-systolic volumeIschemic decreaseCoronary angioplastyVentricular functionElectrocardiographic changesElectrocardiographic monitoringBalloon angioplastyCoronary artery
1990
Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol®11Fluosol® (20% Intravascular Perfluorochemical Emulsion) is a registered trademark of The Green Cross Corporation, Osaka, Japan.
Kent K, Cleman M, Cowley M, Forman M, Jaffe C, Kaplan M, King S, Krucoff M, Lassar T, McAuley B, Smith R, Wisdom C, Wohlgelernter D. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol®11Fluosol® (20% Intravascular Perfluorochemical Emulsion) is a registered trademark of The Green Cross Corporation, Osaka, Japan. The American Journal Of Cardiology 1990, 66: 279-284. PMID: 2195864, DOI: 10.1016/0002-9149(90)90836-p.Peer-Reviewed Original ResearchConceptsOxygen-carrying perfluorochemical emulsionFluosol perfusionAngioplasty patientsMyocardial ischemiaPerfluorochemical emulsionBaseline levelsGlobal left ventricular ejection fractionLeft ventricular ejection fractionPercutaneous transluminal coronary angioplastyRegional wall dysfunctionSevere anginal painTransluminal coronary angioplastyVentricular ejection fractionST-segment changesAnginal painGreen Cross CorporationCoronary angioplastyEjection fractionMulticenter trialRoutine angioplastyVentricular functionBalloon occlusionBalloon deflationPatient populationBalloon inflation
1987
Silent ischemia during coronary occlusion produced by balloon inflation: Relation to regional myocardial dysfunction
Wohlgelernter D, Jaffe C, Cabin H, Yeatman L, Cleman M. Silent ischemia during coronary occlusion produced by balloon inflation: Relation to regional myocardial dysfunction. Journal Of The American College Of Cardiology 1987, 10: 491-498. PMID: 2957410, DOI: 10.1016/s0735-1097(87)80189-4.Peer-Reviewed Original ResearchConceptsBalloon inflationAsymptomatic groupCoronary angioplastyMyocardial ischemiaPercutaneous transluminal coronary angioplastyRegional left ventricular dysfunctionGlobal left ventricular wall motionTwo-dimensional echocardiographic recordingsLeft ventricular dysfunctionStable exertional anginaAbsence of anginaSilent myocardial ischemiaTransluminal coronary angioplastyRegional myocardial dysfunctionLeft ventricular wall motionST-segment changesSignificant differencesVentricular wall motionPain interviewExertional anginaSilent ischemiaVentricular dysfunctionObstructive lesionsEchocardiographic assessmentComorbid conditions